KRAS and colorectal cancer: We also interrogated a real-world clinicogenomic database (CGDB) to assess prognostic implications for KRAS mutated subsets compared to other genomically defined cohorts of NSCLC, colorectal cancer (CRC), and pancreatic ductal adenocarcinoma (PDAC).